SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001137050-14-000100
Filing Date
2014-05-19
Accepted
2014-05-19 14:00:28
Documents
11
Period of Report
2014-03-31

Document Format Files

Seq Description Document Type Size
1 antiviral10qafinal.htm 10-Q/A 15847
2 exhibit311.htm EX-31 6052
3 exhibit312.htm EX-31 6080
4 exhibit321.htm EX-32 2248
5 exhibit322.htm EX-32 2192
  Complete submission text file 0001137050-14-000100.txt   2096643

Data Files

Seq Description Document Type Size
6 avrt-20140331.xml EX-101.INS 344386
7 avrt-20140331.xsd EX-101.SCH 24683
8 avrt-20140331_lab.xml EX-101.LAB 107386
9 avrt-20140331_pre.xml EX-101.PRE 104129
10 avrt-20140331_cal.xml EX-101.CAL 6325
11 avrt-20140331_def.xml EX-101.DEF 33663
Mailing Address SUITE 1211, TOWER 2, SILVERCORD 30 CANTON ROAD, TSIMSHATSUI KOWLOON K3 00000
Business Address SUITE 1211, TOWER 2, SILVERCORD 30 CANTON ROAD, TSIMSHATSUI KOWLOON K3 00000 852-2317-1291
ANTIVIRAL TECHNOLOGIES, INC. (Filer) CIK: 0001445226 (see all company filings)

IRS No.: 261188469 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 000-53449 | Film No.: 14854160
SIC: 6770 Blank Checks